Fig 1.
Kabeho Study Cohort Screening and Enrollment Diagram.
Table 1.
Characteristics of HIV-Infected Pregnant and Postpartum Women at Study Enrollment (N = 608)*.
Fig 2.
Distribution of viral load results at enrollment by time on ART.
(A) Time on ART for all study women with duration and VL information available. (B) Time on ART only for study women on ART < 4 months with VL results available. Both figure parts exclude one woman with an outlying VL result of 900,000 copies/ml and <1 month on ART for ease of viewing.
Table 2.
Unadjusted and adjusted odds ratios from GEE models—examining the likelihood of detectable viral load at enrollment in pregnant and postpartum Kabeho Study participants.
Fig 3.
Distribution of viral load results at enrollment by time on ART among women with and without HIV drug resistance (major NRTI and NNRTI mutations only).